NEU neuren pharmaceuticals limited

Ann: Neuren approaching key milestones in Q4 2019, page-113

  1. 2,981 Posts.
    lightbulb Created with Sketch. 643
    What does our SP suggest with regards to NEU being a t/o target in the short term? Little to no chance?

    I still believe NEU will be eventually taken out by however goes after Acadia, not Acadia themselves.

    Acadia's value will increase substantially if trofinetide gets through phase 3, and they are going to know that soon enough. If they have got confidence in that trial, and why wouldn't they, then they are only a few months away from being worth more than their current MC of $6 billion.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.100(0.80%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.44 $12.73 $12.13 $11.07M 885.6K

Buyers (Bids)

No. Vol. Price($)
1 1215 $12.52
 

Sellers (Offers)

Price($) Vol. No.
$12.54 804 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.